Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion type Assertion NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_head.
- NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion description "[Inhibition of oxidative stress, nitric oxide production, expression of endogenous retroviral and repetitive elements such as HRES-1, the long interspersed nuclear elements 1, Trex1, interferon alpha (IFN-alpha), toll-like receptors 7 and 9 (TLR-7/9), high-mobility group B1 protein, extracellular signal-regulated kinase, DNA methyl transferase 1, histone deacetylase, spleen tyrosine kinase, proteasome function, lysosome function, endosome recycling, actin cytoskeleton formation, the nuclear factor kappa B pathway, and activation of cytotoxic T cells showed efficacy in animal models of lupus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_provenance.
- NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion evidence source_evidence_literature NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_provenance.
- NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion SIO_000772 20014960 NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_provenance.
- NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion wasDerivedFrom befree-20150227 NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_provenance.
- NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_assertion wasGeneratedBy ECO_0000203 NP863891.RA2_xI74Y8eJKpNo9iOf3_lE3GrHiSORQGVu9OSne-LqE130_provenance.